Dual role of α7 nicotinic acetylcholine receptors in the retrosplenial cortex for aversive memory acquisition and retrieval

TL;DR

This study explores how α7 nicotinic receptors in the retrosplenial cortex affect aversive memory and could be important for Alzheimer's disease treatment.

Contribution

The study identifies a dual role of α7 nicotinic receptors in aversive memory acquisition and retrieval in the retrosplenial cortex.

Findings

α7 nicotinic receptors in the aRSC are involved in aversive memory acquisition and expression.

α7 nicotinic receptors do not play a role in memory consolidation.

These receptors are highlighted as potential therapeutic targets for Alzheimer's disease.

Abstract

In the retrosplenial cortex (RSC), the role of cholinergic modulation via α7 nicotinic receptors and their involvement in memory is unknown. In recent years, the RSC has been shown to deteriorate in the early stages of Alzheimer’s disease (AD). Likewise, the cholinergic system has been postulated as one of those responsible for cognitive impairment in patients with AD. Great interest has arisen in the study of α7 nicotinic receptors as more specific targets for the treatment of this disease. For this reason, we aim to study the role of α7 receptors of the RSC in memory processing. We infused a selective α7 receptor antagonist into the anterior part of the RSC (aRSC) to assess its role in different phases of aversive memory processing using an inhibitory avoidance task. We found that α7 nicotinic receptors are involved in memory acquisition and expression, but not in its consolidation. These results identify aRSC α7 nicotinic receptors as key players in aversive memory processing and highlight their significant potential as therapeutic targets for Alzheimer’s disease.

Figures